top of page
Newspaper
Writer's pictureDEBRA International

Take part: RHEACELL phase 3 clinical trial on systemic stem cell therapy for wound healing in RDEB/JEB

This clinical trial, which is now actively recruiting for children and adults with a confirmed diagnosis of recessive dystrophic EB (RDEB) or junctional EB (JEB), is focused on testing whether stem cell therapies could help enable the body to close chronic wounds associated with these two types of EB.


The trial is looking for 74 patients with severe forms of EB in various renowned study centers across Europe (EU and UK), Israel, Chile, Argentina, and the US. The study is recruiting and looking for patients (children and adults) with a confirmed diagnosis of recessive dystrophic EB (RDEB) or junctional EB (JEB).


RHEACELL, the commissioning biopharmaceutical company, will cover travel and accommodation expenses for all participants.


If you are interested in participating, please talk to your EB clinician about whether you meet the inclusion criteria and which study site would be suitable for you.




126 views0 comments

Recent Posts

See All

Am Heumarkt 27/1 | 1030 Vienna | Austria

  • facebook
  • twitter
  • linkedin

DEBRA International is a charitable Association registered in Austria (ZVR 932762489)

© 2023 DEBRA International. All rights reserved. Disclaimer: any and all medical information provided by DEBRA International on this website is for informational purposes only. Information is not intended to substitute the care and guidance given by a qualified physician or other allied healthcare professional. Always seek the advice of your physician prior to starting any medications or treatment regimens. DEBRA International does not endorse any drugs, tests, or treatments that we may report.

bottom of page